Navigation Links
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
Date:11/25/2008

NEW YORK,Nov. 25 /PRNewswire-FirstCall/ -- AngioGenex, Inc. (OTC Bulletin Board: AGGX) is a New York-based biotechnology company that leads in targeting Id genes and proteins for the discovery and development of anti-angiogenic drugs to treat cancer. Today the Company announced achievement of its 2008 objectives and its key business goals for 2009.

AngioGenex accomplished a number of important milestones that it set for itself in 2008. In the Research and Development area, the Company completed key pilot studies on novel anti-angiogenic drugs and filed US and foreign patent applications for these agents. A major goal of 2008 was to complete in vivo studies of its lead small molecule drug candidate (AGX51) that would establish the ability of the agent to reduce angiogenesis and to block the growth and metastasis of tumors. According to Dr. Garland, "the data from those studies clearly met this goal and AGX51 has the potential of being the first orally active anti-angiogenic drug that acts by a mechanism not associated with VEGF, the target of Avastin(R), Genentech's blockbuster anti-cancer drug." Moreover, the results demonstrated that mice tolerate AGX51 without any apparent side effects.

In the corporate area, Dr. Richard Salvador, the former global head of Preclinical Development at Hoffmann La Roche, Inc. became Chairman of the Board of Directors and Dr. Garland, who has led the company's drug discovery and development effort, became the CEO.

AngioGenex took important steps to satisfy its near term corporate finance needs and to meet its future capital formation goals. The Company raised a modest amount of equity capital from new and existing shareholders to fund the AGX51 pilot studies, and it retained Griffin Securities LLC, an investment banking firm specializing in early stage biotechnology companies. Working with Griffin, the Company has identified a number of potential corporate pa
'/>"/>

SOURCE AngioGenex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. William Garland Joins AngioGenexs New Board of Directors
2. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
3. CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market
4. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
5. Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
6. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
7. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
8. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
9. Millennium Over-Delivers on 2007 Goals and Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Louis, MO (PRWEB) May 21, 2015 ... assesses the safety and efficacy of pharmaceutical products and ... Drive Maryland Heights, MO 63043, a 50,000 sq. ft. ... current location, to enable strategic growth. Facility renovations will ... to the new space will occur in September. ...
(Date:5/21/2015)... , May 21, 2015  Susan Hedstrom, Executive ... a nonprofit organization dedicated to supporting research to ... (PWS), announced today that FPWR has received the ... Irina Shaulov contributed $1 million in support ... "Our gift ...
(Date:5/21/2015)... CA (PRWEB) May 21, 2015 ... has announced a partnership with PicnicHealth, a healthcare ... patients. Participants diagnosed with Inflammatory Bowel Disease (IBD) ... as a complementary uBiome research kit. Both companies ... , For more information on ...
(Date:5/21/2015)... -- Imagine being able to probe and ... others. Being able to read faces and enjoy genuine ... anticipate their thoughts and actions like never before. Use ... create unique abstract paintings and video, or, play a ... first-person-shooter as it creates action, dialog, and outcomes based ...
Breaking Biology Technology:Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 35 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2
... , Industry Leading Health IT Providers Collaborate to Demonstrate ... Utilization of RFD Standard , , CARROLLTON, Ga., ... of an integrated electronic health record (EHR), practice management ... Drug Information Association,s (DIA) 45th annual convention taking place ...
... Sciences, Inc. (Nasdaq: HGSI ) announced today that its ... and may be accessed at www.hgsi.com . , ... , , A member of Human Genome Sciences, senior management ... at 10:30 am GMT (6:30 am Eastern Time). , , ...
... the critical role a certain gene and its protein play ... and skull. In a study posted online June 15 ... , a research team at Cincinnati Children,s reports that too ... activity of what are called neural crest cells. These cells, ...
Cached Biology Technology:Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show 2Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show 3Scientists identify gene vital to early embryonic cells forming a normal heart and skull 2
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... is being developed by researchers at Cardiff University. ... Aureus) are resistant to one of more conventional antibiotic ... infection. , A team in the School of Medicine's ... Wellcome Trust to commercially develop a protein based therapeutic ...
... assembly can be accelerated with the assistance of the ... of researchers at the U.S. Department of Energy's Brookhaven ... the order of billionths of a meter, could potentially ... storage, as well as improved methods for diagnosing and ...
... recently executed an exclusive license agreement for a ... (IBS), Inc. This innovative DNA-sequencing technology was invented ... and head of DNA Sequencing and Chemical Biology ... Center at Columbia University. The fundamentals of this ...
Cached Biology News:Nanoparticle assembly enters the fast lane 2Columbia University licenses next-generation DNA sequencing technology 2
... BioGenex Super Sensitive MultiLink IHC ... species-specific secondary antibodies, labeled with ... to the bound primary antibody, ... a Streptavidin-Enzyme conjugate. This kit ...
Sf21 Insect Cells (Live) in Max-XP Medium...
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
... unit is an inexpensive personal or mini thermal ... process. Lightweight, with a small footprint, it can ... the researcher's desk. , The Gene Cycler thermal ... not have access to a large laboratory thermal ...
Biology Products: